Chinese researchers have made a significant advancement in cancer immunotherapy by developing an efficient method to mass-produce powerful tumor-killing natural killer (NK) cells from stem cells. Led by Professor Jinyong Wang at the Institute of Zoology, Chinese Academy of Sciences, the team has created a scalable process that starts with CD34+ hematopoietic stem and progenitor cells (HSPCs) sourced from umbilical
Continue Reading